| ASV | anodic stripping voltammetry; antisiphon valve; antisnake venom; avian sarcoma virus |
|---|---|
| BWSV | black widow spider venom |
| CoVF | cobra venom factor |
| CVF | cardiovascular failure; central visual field; cervicovaginal fluid; cobra venom factor |
| dRVVT | dilute Russell viper venom time |
| BV | Bee venom |
|---|---|
| BWSV | Black Widow Spider Venom |
| CVF | Cobra Venom Factor |
| CoF | Cobra venom factor |
| CoVF | Cobra venom factor |
zymologist
| substrate | <chemistry> A substance upon which an enzyme acts. Origin: L. Stratum = layer (18 Nov 1997) |
|---|---|
| substrate cycle | <biochemistry> Any seqence of enzyme catalysed reactions in which the forward and reverse processes (catalysed by different enzymes) are consititutively active. Frequently used to describe the cycle of phosphorylation and dephosphorylation of phosphatidyl inositol derivatives in cell membranes. (05 Jan 1998) |
| substrate cycling | A set of opposing, nonequilibrium reactions catalyzed by different enzymes which act simultaneously, with at least one of the reactions driven by ATP hydrolysis. The results of the cycle are that ATP energy is depleted, heat is produced and no net substrate-to-product conversion is achieved. Examples of substrate cycling are cycling of gluconeogenesis and glycolysis pathways and cycling of the triglycerides and fatty acid pathways. Rates of substrate cycling may be increased many-fold in association with hypermetabolic states resulting from severe burns, cold exposure, hyperthyroidism, or acute exercise. (12 Dec 1998) |
| substrate inhibition | Inhibition of an enzyme activity by a substrate of the reaction catalyzed by that enzyme; often, this type of inhibition occurs at elevated substrate levels in which the substrate is binding to a second, non-active site on the enzyme. (05 Mar 2000) |
| substrate-level phosphorylation | Synthesis of high-energy phosphate bonds through reaction of inorganic phosphate with an activated (usually) organic substrate. (09 Oct 1997) |
| substrate specificity | A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. (12 Dec 1998) |
| suicide substrate | A competitive inhibitor that is converted to an irreversible inhibitor at the active site of the enzyme. Synonym: mechanism-based inhibitor. (05 Mar 2000) |
| insulin receptor substrate-1 protein | <chemical> Amino acid sequence given in first source; a 180 kD protein that contains multiple phosphorylated tyrosine residues after insulin stimulation; human and rat forms (hirs-1 and irs-1) are homologous Synonym: insulin receptor substrate-1-like protein, irs-1 protein, irs-1 gene product, hirs-1 protein, hirs-1 gene product, insulin receptor substrate 1, insulin receptor substrate-1 (05 Dec 1998) |
| enzyme-substrate complex | A noncovalent complex of two molecules; often referring to the enzyme-substrate complex in an enzyme-catalyzed reaction. Compare: central complex, Michaelis complex. Synonym: enzyme-substrate complex. (05 Mar 2000) |
| black widow spider venom | Potent neurotoxin that induces catastrophic release of acetylcholine from presynaptic terminals of cholinergic chemical synapses. (18 Nov 1997) |
| venom | <chemical> A toxic secretion in animals that is actively delivered to the target organism, either to paralyse or incapacitate or else to cause pain as a defence mechanism. Commonly include protein and peptide toxins. (12 Jan 1998) |
| venom haemolysis | That caused by haemolytic material in the venom of various species of snakes or other venomous animals. (05 Mar 2000) |
| Russell's viper venom | A venom used as a coagulant in the arrest of haemorrhage from accessible sites in haemophilia. (05 Mar 2000) |
| Russell's viper venom clotting time | A clotting time determination performed on citrated platelet-poor plasma using Russell's viper venom as an activating agent. This allows activation of factor X directly without the need for other coagulation factors and is used to confirm factor X defects. See: Stypven time test. (05 Mar 2000) |
| cobra venom cofactor | <enzyme> A glycine-rich, heat-labile beta-glycoprotein found in blood. It is a proactivator of complement 3 in the alternate pathway of complement activation. Factor b is converted by factor d to c3 convertase. Registry number: EC 3.4.21.47 (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|